Verzenio 100 MG tablet UU 14S
Ended Awarded Last action
- Contract number
- SPE2DR26F20ZR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $79,160
Award facts
- Contract value 100% obligated
- $79,160.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $79,160.25, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for the supply of Verzenio 100 mg tablets in quantities of 14 units. The contract was awarded on January 20, 2026, with an ultimate completion date of January 21, 2026, and carries no set-aside designation, indicating it was competitively awarded. The Defense Logistics Agency funded this procurement, with performance taking place at Amerisourcebergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare systems worldwide.
Verzenio (abemaciclib) is an oncology medication used in the treatment of certain breast cancers, representing part of the broader pharmaceutical portfolio that Amerisourcebergen supplies to federal healthcare programs. As a major pharmaceutical distributor, Cencora, Inc. and its subsidiary Amerisourcebergen have consistently fulfilled federal medical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The company's capacity to deliver critical pharmaceutical products through its prime IDC with DLA positions it as a key vendor for supporting Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26F20ZR?
SPE2DR26F20ZR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F20ZR worth?
The government has obligated $79,160 on SPE2DR26F20ZR.
Is contract SPE2DR26F20ZR an order under another contract?
Yes. SPE2DR26F20ZR is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20ZR competed?
The extent of competition for SPE2DR26F20ZR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award